![Matthew Brams](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Brams
Oprichter bij
CINGULATE INC.
Vermogen: 33 933 $ op 31-05-2026
Profiel
Matthew N.
Brams is the founder of Cingulate, Inc., founded in 2012, where the title held is Chief Medical Officer & Executive Vice President.
Dr. Brams is the founder of Cingulate Works, Inc., founded in 2013, where the title held is Chief Medical Officer & Executive Vice President.
Dr. Brams is also the founder of Cingulate Therapeutics LLC..
Dr. Brams currently works at Baylor College of Medicine as a Clinical Associate Professor.
Formerly, Dr. Brams was Medical Director & Principal at Bayou City Research, Inc. from 1999 to 2021.
Education includes undergraduate studies at The University of Texas at Austin and a doctorate from The University of Texas Health Science Center at Houston.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CINGULATE, INC. 0,06% | 18-05-2026 | 8.157 ( 0,06% ) | 33 933 $ | 31-05-2026 |
Actieve functies van Matthew Brams
| Bedrijven | Functie | Begin |
|---|---|---|
| CINGULATE INC. | Oprichter | 01-05-2012 |
Cingulate Therapeutics LLC
 Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that focuses on develops attention deficit/hyperactivity disorder products | Oprichter | - |
Cingulate Works, Inc.
 Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals for the treatment of central nervous system and neurobiological disorders | Oprichter | 01-01-2013 |
Baylor College of Medicine
 Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Eerdere bekende functies van Matthew Brams
| Bedrijven | Functie | Einde |
|---|---|---|
Bayou City Research, Inc. | Hoofd Techniek/Wetenschap/O&O | 01-01-2021 |
Opleiding van Matthew Brams
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
54
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Cingulate Therapeutics LLC
Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that focuses on develops attention deficit/hyperactivity disorder products | Health Technology |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas Health Science Center at Houston
 The University of Texas Health Science Center at Houston Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals for the treatment of central nervous system and neurobiological disorders | Health Technology |
Cingulate, Inc.
 Cingulate, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Bayou City Research, Inc. |
